On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...